Cargando…

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction

BACKGROUND: Acute coronary syndrome (ACS) is a common condition that needs appropriate treatment like percutaneous coronary intervention (PCI). Glycoprotein IIb/IIIa inhibitors (GPI) like eptifibatide prevent procedural ischemic complications after PCI. Eptifibatide has increased the risk of bleedin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shemirani, Hasan, Khosravi, Alireza, Eghbal, Ali, Amirpour, Afshin, Roghani, Farshad, Hashemi-Jazi, Seyed Mohammad, Pourmoghaddas, Ali, Heidari, Ramin, Sajjadieh, Amir, Sadeghi, Nahid, Sanei, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884730/ https://www.ncbi.nlm.nih.gov/pubmed/31819752 http://dx.doi.org/10.22122/arya.v15i4.1668

Ejemplares similares

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016)

The effect of intracoronary versus intralesional injection of eptifibatide on myocardial perfusion outcomes during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction; A randomized clinical trial study
por: Ghazal, Abdullatef, et al.
Publicado: (2019)

Factors affecting outcome of primary percutaneous coronary intervention for acute myocardial infarction
por: Sadrnia, Saeid, et al.
Publicado: (2013)

Undesired Outcomes of the Catania Stent Compared to the Xience Stent in Patients Undergoing Angioplasty: A Double-Blind Randomized Controlled Trial
por: Pourmoghaddas, Masoud, et al.
Publicado: (2017)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Effects of streptokinase on reflow in rescue percutaneous coronary intervention
por: Sanatkar, Masoud, et al.
Publicado: (2013)

Comparison of no-reflow phenomenon after percutaneous coronary intervention for acute myocardial infarction between smokers and nonsmokers
por: Shemirani, Hassan, et al.
Publicado: (2014)

Diagnostic performance of 64-row coronary CT angiography in detecting significant stenosis as compared with conventional invasive coronary angiography
por: Sajjadieh, Amirreza, et al.
Publicado: (2013)

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients
por: Jalalian, Rozita, et al.
Publicado: (2021)

Renal ablation for treatment of hypertension without Symplicity catheter: The first human experience
por: Honarvar, Mehrdad, et al.
Publicado: (2013)

RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms
por: Bavand Savadkouhi, Maryam, et al.
Publicado: (2017)

Survey of coronary catheterization laboratory activity in Iran during the coronavirus disease-2019 pandemic
por: Kermani-Alghoraishi, Mohammad, et al.
Publicado: (2021)

The Relation Between Ankle-Brachial Index (ABI) and Coronary Artery Disease Severity and Risk Factors: An Angiographic Study
por: Sadeghi, Masoumeh, et al.
Publicado: (2011)

The transulnar approach in the patients with ipsilateral radial artery occlusion
por: Roghani-Dehkordi, Farshad, et al.
Publicado: (2020)

Resistin and prooxidant-antioxidant balance: Markers to discriminate acute coronary syndrome from stable angina
por: Pourmoghaddas, Ali, et al.
Publicado: (2020)

Predictive value of P-wave duration and dispersion in post coronary artery bypass surgery atrial fibrillation
por: Hashemi Jazi, Mohammad, et al.
Publicado: (2012)

Association of serum potassium level with ventricular tachycardia after acute myocardial infarction
por: Pourmoghaddas, Ali, et al.
Publicado: (2012)

Compare Complication of Classic versus Patent Hemostasis in Transradial Coronary Angiography
por: Roghani, Farshad, et al.
Publicado: (2017)

Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010)

Clinical and economic studies of eptifibatide in coronary stenting
por: Pasala, Tilak, et al.
Publicado: (2014)

A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Immediate results and six-month outcomes after percutaneous coronary intervention in a referral heart center in Isfahan, Iran
por: khosravi, Alireza, et al.
Publicado: (2011)

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia
por: Byrne, John, et al.
Publicado: (2015)

Comparison of survival rate and complications of percutaneous coronary intervention, coronary artery bypass graft, and medical treatment in patients with left main and/or three vessel diseases
por: Khosravi, Alireza, et al.
Publicado: (2020)

Trans-snuff box approach as a new access site for coronary angiography and angioplasty versus trans-radial approach in terms of feasibility, safety, and complications
por: Roghani-Dehkordi, Farshad, et al.
Publicado: (2020)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Comparison of pain severity, satisfaction, and complications of proximal and distal forearm anesthesia in patients undergoing trans-palmar coronary angiography
por: Roghani-Dehkordi, Farshad, et al.
Publicado: (2021)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010)

How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
por: Allam, Hesham, et al.
Publicado: (2013)

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020)

Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)

Primary percutaneous coronary intervention in the Isfahan province, Iran; A situation analysis and needs assessment
por: Reza Khosravi, Ali, et al.
Publicado: (2013)

Effect of cardiac rehabilitation on metabolic syndrome and its components: A systematic review and meta-analysis
por: Sadeghi, Masoumeh, et al.
Publicado: (2016)

Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels
por: Pourmoghaddas, Ali, et al.
Publicado: (2014)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7qigesfspsn4r624gg5n795cr